Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Predict S.P.A. Class B ( (IT:PRE) ) has provided an announcement.
Predict S.p.A.’s Imaging strategic business unit has secured a €513,000 contract to supply 11 multidisciplinary ultrasound scanners to the ASL BAT health authority in the Barletta-Andria-Trani province, reinforcing its role in diagnostic imaging for operating rooms and intensive care units. The award, funded through European and Italian development programs, includes full-risk warranties and underscores Predict’s operational reliability and ability to capture public-sector tenders by combining technology delivery with technical support and assistance.
The contract covers six latest-generation ultrasound systems for surgical and intensive care settings and five scanners configured for oncological screening in district outpatient clinics, supporting ASL BAT’s efforts to upgrade equipment and strengthen cancer screening pathways for a population of about 400,000 residents. By coordinating its Imaging and People Support units to ensure continuity and efficiency of the installed devices, Predict consolidates its long-standing presence in the region and enhances its positioning in Italy’s diagnostic imaging market, with clear benefits for healthcare providers and patients through improved access to advanced diagnostic tools.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.40 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an innovative Italian medtech SME focused on in vivo diagnostics through the distribution of ultrasound and radiology equipment and the development of breath analysis and digital healthcare technologies. Organized into four strategic business units, it offers imaging support, non-invasive oncological screening via breath analysis, and augmented reality and robotics tools for healthcare and education, supported by partnerships with major Italian hospitals and universities and a growing presence that now includes a Milan office.
Average Trading Volume: 25,534
Technical Sentiment Signal: Sell
Current Market Cap: €5.56M
For a thorough assessment of PRE stock, go to TipRanks’ Stock Analysis page.